Navigation Links
Study finds blood cells can be reprogrammed to act as embryonic stem cells
Date:4/20/2009

similar to ES cells, the scientists analyzed the CD34+ iPS cell lines to see if they had acquired stem cell "markers," the unique combination of proteins that coat the cells' surface and distinguish them from other types of cells. Indeed, the iPS cell lines expressed the same markers as ES cells and further shared the capacity to differentiate into a variety of specialized cell types.

In vitro, the iPS cells readily developed into clusters of cells called embryoid bodies from which cells of virtually any type can develop. These differentiated cells expressed genes for all three embryonic germ layers (the tissues from which all other tissue types in the body develop) and also produced myeloid and granulocyte colonies (types of white blood cells).

The group confirmed that the reprogrammed cells had acquired ES cell characteristics by injecting the newly reprogrammed cells into immunodeficient mice. The cells successfully generated well-differentiated teratomas, benign masses containing all three embryonic germ layers, including respiratory, bone, and neural tissue.

"Not only has this work identified a new programmable cell type, but the cells are easy to obtain and analyze in many research laboratories and bone marrow transplantation centers around the world," said Grover C. Bagby, MD, Professor of Medicine and Molecular and Medical Genetics at Oregon Health and Science University, who is not affiliated with the study. "These findings will immediately enhance the pace of laboratory research in this field and will ultimately help to determine whether iPS cells have a therapeutic potential equivalent to that of embryonic stem cells."


'/>"/>

Contact: Patrick C. Irelan
pirelan@hematology.org
202-776-0544
American Society of Hematology
Source:Eurekalert

Page: 1 2

Related biology news :

1. New human study reinforces antioxidant benefits of tart cherries
2. Lab study shows THC exposure as adolescents linked to negative effects of THC as adults
3. Study reveals potential to amass more carbon in eastern North American forests
4. Tentacles of venom: New study reveals all octopuses are venomous
5. Rutgers study finds many consumers ignore food product recalls
6. UC Riverside biochemist to study how crops can increase protein production
7. Study finds multidrug-resistant gram-negative bacteria high in long-term care
8. UNC study: Scientists identify chemical compound that may stop deadly brain tumors
9. Study compares sound from exploding volcanoes with jet engines
10. UIC biologists use DNA to study migration of threatened whale sharks
11. Study reveals potential to amass more carbon in eastern North American forests
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/5/2015)... , Jan. 26, 2015   Epic Sciences , a ... today announced that Murali Prahalad , Ph.D., president and ... World Conference (PMWC) 2015: Silicon Valley, which is taking ... View, Calif. on January 26-28, 2015. ... of Age as Biomarkers." Last year, Epic Sciences was a ...
(Date:2/5/2015)... 2015   Marvin Test Solutions , ... test solutions for military, aerospace, and manufacturing ... TS-323 GENASYS Test Platform to ... is a high-performance PXI-based system designed to ... require performance functional testing. GENASYS features a ...
(Date:2/5/2015)... 28, 2015 NXT-ID, Inc. (NASDAQ: ... biometric authentication company focused on the growing mobile commerce ... Global Online CEO Conference on January 29 th ... Pereira , CEO of NXT-ID will present and host ... Wocket smart wallet and its full suite of biometric ...
Breaking Biology News(10 mins):Epic Sciences to Present at Personalized Medicine World Conference 2015 on the Use of Circulating Tumor Cells as Cancer Biomarkers 2Marvin Test Solutions' GENASYS Platform Advances Mission-Critical Aerospace Production Test 2Marvin Test Solutions' GENASYS Platform Advances Mission-Critical Aerospace Production Test 3Marvin Test Solutions' GENASYS Platform Advances Mission-Critical Aerospace Production Test 4CEO of NXT-ID, Inc. to Discuss Company's Biometric Technologies at RedChip Online Conference January 29th 2CEO of NXT-ID, Inc. to Discuss Company's Biometric Technologies at RedChip Online Conference January 29th 3
... York, NY) The Parkinson,s Disease Foundation (PDF) is pleased ... the potential of individualized stem cell therapy to treat ... research of Marina Emborg, M.D., Ph.D., and Su-Chun Zhang, ... This award was chosen as part of PDF,s ...
... DCGeorgetown University Medical Center and Oak Ridge ... the institutions that formalizes their research relationship ... in the areas of structural biology, systems ... The Comprehensive Research and Development Agreement ...
... 23, 2008 -- Eight Oak Ridge National Laboratory nanomanufacturing ... Department of Energy,s Industrial Technologies Program. The awards, ... $1.6 million to partners, are the result of a ... The awards are for the following projects: ...
Cached Biology News:Parkinson's Disease Foundation announces award of $150,000 2GUMC and Oak Ridge National Labs announce unique research partnership 2GUMC and Oak Ridge National Labs announce unique research partnership 3ORNL nanotechnologies big winners in DOE call 2ORNL nanotechnologies big winners in DOE call 3
(Date:2/26/2015)... YORK , Feb. 26, 2015 S&P ... Factual Stock Report coverage on MabVax Therapeutics Holdings ... (MBVX) is a clinical stage biotechnology company focused on ... unmet medical needs in the treatment of cancer. MabVax ... based on the protective immune responses generated by patients ...
(Date:2/26/2015)... /PRNewswire/ - SQI Diagnostics Inc. ("SQI" or the "Company") ... develops and commercializes proprietary technologies and products for advanced ... for the fiscal first quarter ended December  31, 2014. ... dollars (CAD), unless otherwise stated. "During ... from our existing customers and add to our sales ...
(Date:2/26/2015)... Feb. 26, 2015 Protiviti ( www.protiviti.com ), ... of the Governance Portal , designed to increase ... compliance (GRC) tasks across multiple business units and projects. ... help customers better align their controls with the COSO ... ) requirements. In response to client feedback, Protiviti has ...
(Date:2/26/2015)... Woodbridge, NJ (PRWEB) February 26, 2015 ... and its affiliated companies, Wilentz, Goldman & ... in a trade secrets lawsuit against Genewiz Inc. in ... illegally obtained and utilized GenScript’s trade secrets, and that ... The court entered an order denying motions for ...
Breaking Biology Technology:S&P Capital IQ Initiates Coverage on MabVax Therapeutics Holdings Inc. in S&P Capital IQ Factual Stock Reports 2S&P Capital IQ Initiates Coverage on MabVax Therapeutics Holdings Inc. in S&P Capital IQ Factual Stock Reports 3S&P Capital IQ Initiates Coverage on MabVax Therapeutics Holdings Inc. in S&P Capital IQ Factual Stock Reports 4S&P Capital IQ Initiates Coverage on MabVax Therapeutics Holdings Inc. in S&P Capital IQ Factual Stock Reports 5SQI Diagnostics Reports First Quarter Financial Results 2SQI Diagnostics Reports First Quarter Financial Results 3SQI Diagnostics Reports First Quarter Financial Results 4SQI Diagnostics Reports First Quarter Financial Results 5SQI Diagnostics Reports First Quarter Financial Results 6Protiviti Governance Portal Helps Companies Drive Governance, Risk and Compliance Productivity Across Multiple Business Units 2Protiviti Governance Portal Helps Companies Drive Governance, Risk and Compliance Productivity Across Multiple Business Units 3Wilentz Client GenScript Awarded $10 Million in Trade Secrets Case Against Genewiz 2Wilentz Client GenScript Awarded $10 Million in Trade Secrets Case Against Genewiz 3
... Feb. 27 Tengion Inc., a clinical,stage regenerative ... neo-vessels, announced today that it has appointed Jeff,Randall ... more than 25 years,experience as a senior- level ... to Tengion, including expertise in the healthcare, device,manufacturing ...
... CHARLESTON, S.C., Feb. 27 JSJ Pharmaceuticals ... new aesthetic division,Vitivia(TM). Vitivia(TM) will focus on ... of JSJ Pharmaceuticals in the development of,science-based, ... will be its Pro:Vitamin line.,Topical vitamins have ...
... February 27 Debiopharm Group,(Debiopharm), a global ... conditions and particularly oncology, today,announced the establishment ... Ecole,Polytechnique Federale de Lausanne (EPFL), focusing on ... 2.5 million endowment, the objective,of the chair ...
Cached Biology Technology:Tengion Appoints Jeff Randall to Board of Directors 2JSJ Pharmaceuticals Announces Launch of Aesthetic Division - Vitivia(TM) 2Debiopharm and EPFL Establish an Oncology Chair 2
FRACTALKINE [Human] (Recombinant)...
... For the ultimate in utility and ... to meet the needs of the researcher. ... interior dimensions or as sheet material that ... enclosures. These isolators are autoclavable and non-cytotoxic ...
Argon Calibration Source...
SHEEP ANTI ESCHERICHIA COLI...
Biology Products: